XML 42 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation
12 Months Ended
Dec. 31, 2020
Stock-Based Compensation  
Stock-Based Compensation

12. Stock-Based Compensation

Total compensation cost recognized for all stock-based compensation awards in the consolidated statements of operations was as follows (in thousands):

    

    

Year Ended

December 31, 

2020

2019

Research and development

$

11,580

$

13,538

General and administrative

 

11,576

 

13,705

Total stock-based compensation expense

$

23,156

$

27,243

Restricted Stock and Restricted Stock Unit Awards

The following table summarizes restricted stock and restricted stock unit awards activity for the instruments discussed above as of December 31, 2019 and 2020 is as follows:

    

    

Weighted

Average

Grant Date

Fair Value

Shares

Per Share

Unvested restricted stock and restricted stock unit awards as of December 31, 2019

 

581,408

$

24.03

Issued

 

364,549

$

29.57

Vested

 

(304,638)

$

23.37

Forfeited

(133,869)

$

24.72

Unvested restricted stock and restricted stock unit awards as of December 31, 2020

 

507,450

$

27.35

The expense related to restricted stock and restricted stock unit awards granted to employees and non-employees was $2.8 million and $1.6 million, respectively, for the year ended December 31, 2020. The expense related to restricted stock and restricted stock unit awards granted to employees and non-employees was $4.7 million and $1.6 million, respectively, for the year ended December 31, 2019. The expense related to restricted stock and restricted stock unit awards granted to employees and non-employees was $0 million and $2.4 million, respectively, for the year ended December 31, 2018.

As of December 31, 2020, total unrecognized compensation expense related to unvested restricted stock and restricted stock unit awards was $11.9 million, which the Company expects to recognize over a remaining weighted-average period of 2.7 years.

Stock Options

The following is a summary of stock option activity for the year ended December 31, 2020:

    

    

Weighted Average

    

Remaining

    

Aggregate Intrinsic

Shares

Exercise Price

Contractual Life (years)

Value (in thousands)

Outstanding at December 31, 2019

 

4,358,291

$

25.40

7.4

$

26,060

Granted

1,721,748

$

30.44

Exercised

(964,412)

$

20.22

Cancelled

(1,203,370)

$

30.72

Outstanding at December 31, 2020

 

3,912,257

$

27.26

7.9

$

167,640

Exercisable at December 31, 2020

 

1,463,668

$

24.05

6.8

$

67,413

The total intrinsic value of options exercised for the years ended December 31, 2020, 2019 and 2018 was $15.6 million, $14.6 million, and $15.9 million, respectively.

Using the Black-Scholes option pricing model, the weighted average fair value of options containing service-based vesting granted to employees and directors during the years ended December 31, 2020, 2019, and 2018 was $16.60, $15.67, and $24.91, respectively. The expense related to options containing service-based vesting granted to employees and directors was $16.1 million, $18.1 million, and $19.9 million for the years ended December 31, 2020, 2019, and 2018, respectively.

The fair value of each service-based vesting option issued to employees and directors was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:

    

Year Ended

December 31, 

2020

2019

    

2018

Expected volatility

 

60.0

%  

73.8

%  

77.5

%  

Expected option term (in years)

 

6.25

6.25

6.25

Risk free interest rate

 

1.5

%  

2.0

%  

2.9

%  

Expected dividend yield

 

As of December 31, 2020, total unrecognized compensation expense related to stock options was $40.4 million, which the Company expects to recognize over a remaining weighted-average period of 2.7 years.